Co-Commercialize definition
Examples of Co-Commercialize in a sentence
Akcea will have the right to Co-Commercialize in Major Markets such Products licensed to Novartis.
Each Party shall have the right to opt-out of all of its rights and obligations to Co-Develop and Co-Commercialize any Collaboration Product pursuant to Sections 7.2 and 7.3 below (an “Opt-Out Option”).
The Parties shall Co-Commercialize such Collaboration Products in the Field and share profits equally, subject to the payment obligations in Article 9 and the other terms of this Agreement.
APO(a)-LRx and AKCEA-APOCIII-LRx. Akcea has the right to Co-Commercialize each Product with Novartis in selected markets with the terms and conditions of such Co-Commercialization to be mutually agreed between Akcea and Novartis.
If, on or before the [***] calendar day after * ***Confidential Treatment Requested [***] or [***] for a particular Product, Akcea delivers written notice to Novartis indicating that Akcea intends to Co-Commercialize such Product with Novartis, then the Parties shall negotiate in good faith on the terms and conditions upon which Akcea will Co-Commercialize the Product.
Subject to the terms and conditions of this Agreement and any license agreement within the Aventis Patent Rights, Aventis hereby grants to Regeneron and its Affiliates the nontransferable (except as permitted by Section 20.9), co-exclusive (with Aventis and its Affiliates) right and license under the Aventis Intellectual Property to use, manufacture, import, Co-Develop, Co-Commercialize and Co-Market the VEGF Products during the Term for the purposes of the Collaboration throughout the Territory.
GSK hereby grants to OncoMed the exclusive right, exercisable at OncoMed’s sole discretion, on a Product-by-Product basis, to obtain a co-exclusive (with GSK) worldwide license and, upon OncoMed’s exercise of such right, a license to Co-Commercialize any Product [***] under the terms and conditions set forth in this Agreement.
Subject to the terms and conditions of this Agreement and any license within the Regeneron Patent Rights, Regeneron hereby grants to Novartis and its Affiliates the right and license under the Regeneron Intellectual Property to manufacture, and to Co-Develop, Co-Commercialize and Co-Market the Trap-2 Product throughout the Trap-2 Territory for the Term of this Agreement with respect to the Trap-2 Product.
Subject to the terms and conditions of this Agreement and any license within the Regeneron Patent Rights, Regeneron hereby grants to Novartis and its Affiliates the right and license under the Regeneron Intellectual Property to manufacture, and to Co-Develop, Co-Commercialize and Co-Market the Trap-1 Product throughout the Trap-1 Territory for the Term of this Agreement.
In the event that Regeneron decides it no longer wishes to Co-Commercialize a VEGF Product in a particular Co-Commercialization Country for use in a Therapeutic Area or does not wish to maintain its minimum sales force FTE requirement for use in such Therapeutic Area, Regeneron must give Aventis [***] prior written notice of such decision.